Article
RNA polymerase (rpoB) mutants selected for increased resistance to gyrase inhibitors in Salmonella typhimurium.
Molecular & general genetics : MGG - 25 Jun 1995
Blanc-Potard A B, Gari E, Spirito F, Figueroa-Bossi N, Bossi L
Abstract excerpt
Some rifampicin-resistance (RifR) mutations make bacteria slightly resistant to the gyrase inhibitors novobiocin (Nov) and nalidixic acid (Nal). This suggested that it might be possible to isolate rpoB mutants using either drug for positive selection. In an initial test, we confirmed the presence of Rif-resistant isolates among clones selected for Nov resistance. These mutants are also more resistant to Nal. In a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
